Analyst Gena Wang works at BARCLAYS and is focused on the Healthcare sector with 443 price targets and ratings documented since 2015 spanning on 32 stocks. Previously, Gena Wang worked at JEFFERIES. Analyst's average stock valuation to be materialised ratio is 59.31% with an average time for price targets to be met of 141.32 days.
Most recent stock forecast was given on SLDB, Solid Biosciences Inc at 11-Nov-2022.
Gena Wang best performing recommendations are on SGTX (SIGILON THERAPEUTICS INC).
The best stock recommendation documented was for SGTX (SIGILON THERAPEUTICS INC) at 12/29/2020. The price target of $48 was fulfilled within 2 days with a profit of $10.6 (28.34%) receiving and performance score of 141.71.
Average potential price target upside